M M Redfield
Overview
Explore the profile of M M Redfield including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
63
Citations
2160
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Chen H, Martin F, Gibbons R, Schirger J, Wright R, Schears R, et al.
Heart
. 2009 May;
95(16):1315-9.
PMID: 19447837
Background: B-type natriuretic peptide (BNP, nesiritide) has anti-fibrotic, anti-hypertrophic, anti-inflammatory, vasodilating, lusitropic and aldosterone-inhibiting properties but conventional doses of BNP cause hypotension, limiting its use in heart failure. Objective: To...
2.
Jougasaki M, Grantham J, Redfield M, Burnett Jr J
Peptides
. 2002 Jan;
22(11):1841-50.
PMID: 11754971
Adrenomedullin (ADM), a potent natriuretic and vasorelaxing peptide with inotropic properties, is elevated in plasma in human and experimental congestive heart failure (CHF). Recent studies suggest that angiotensin II stimulates...
3.
Cataliotti A, Malatino L, Jougasaki M, Zoccali C, Castellino P, Giacone G, et al.
Mayo Clin Proc
. 2001 Nov;
76(11):1111-9.
PMID: 11702899
Objectives: To determine levels of natriuretic peptides (NPs) in patients with end-stage renal disease (ESRD) and to examine the relationship of these cardiovascular peptides to left ventricular hypertrophy (LVH) and...
4.
Senni M, Redfield M
J Am Coll Cardiol
. 2001 Nov;
38(5):1277-82.
PMID: 11691495
Three well-controlled epidemiology studies in the U.S. have reported that 40% of incident congestive heart failure (CHF) cases and 50% to 60% of prevalent CHF cases occur in the setting...
5.
Hart C, Burnett Jr J, Redfield M
Am J Physiol Heart Circ Physiol
. 2001 Oct;
281(5):H1938-45.
PMID: 11668054
Anesthetic regimens commonly administered during studies that assess cardiac structure and function in mice are xylazine-ketamine (XK) and avertin (AV). While it is known that XK anesthesia produces more bradycardia...
6.
Elesber A, Redfield M
Mayo Clin Proc
. 2001 Oct;
76(10):1047-52.
PMID: 11605689
Approximately 50% of patients with a firm clinical diagnosis of heart failure (HF) have a normal ejection fraction. Some patients have valvular disease, but most have underlying diastolic dysfunction that...
7.
Maniu C, Redfield M
Expert Opin Pharmacother
. 2001 Oct;
2(6):997-1008.
PMID: 11585015
This review focuses on diastolic dysfunction with special emphasis on isolated diastolic dysfunction where impairment in diastolic function occurs in the absence of concomitant reduction in systolic function. The phenomena...
8.
Hart C, Meyer D, Tazelaar H, Grande J, Burnett Jr J, Housmans P, et al.
Circulation
. 2001 Jul;
104(2):215-20.
PMID: 11447089
Background: The role of load versus angiotensin II (Ang II) and endothelin-1 (ET) in the pathogenesis of hypertensive heart disease is controversial. We sought to determine whether alterations in cardiac...
9.
Hart C, Hahn E, Meyer D, Burnett Jr J, Redfield M
Am J Physiol Heart Circ Physiol
. 2001 Jun;
281(1):H146-54.
PMID: 11406479
beta-Adrenergic hyporesponsiveness in congestive heart failure (CHF) is mediated, in part, by nitric oxide (NO). NO and brain natriuretic peptide (BNP) share cGMP as a second messenger. Left ventricular (LV)...
10.
Ernst E, Shub C, Bailey K, Brown L, Redfield M
J Card Fail
. 2001 Mar;
7(1):13-20.
PMID: 11264545
Background: Cardiac dilatation is a predictor of poor outcome in patients with dilated cardiomyopathy. Whereas cardiac chamber dimensions or volumes can be assessed by various noninvasive and invasive techniques, simple...